Hiroyuki Ohshiro is responsible for in vitro pharmacology, MOA analysis, and new research projects. He has more than 20 years of experience in drug discovery research. Prior to joining PRISM BioLab, he was at RaQualia Phama and led as biology and manager many discovery projects. Hiroyuki worked at Pfizer R&D Japan, he contributed in many projects including pain and gastrointestinal disease areas. He holds an M.S. from Nagoya City University.